A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Clinical trial NCT06666283 · RECRUITING

Trial details

NCT number: NCT06666283
Sponsor: Alebund Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Kidney Disease

Start date: 2025-02-27
Primary completion: 2025-09-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.